+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Biomarker Diagnostic Kits Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 118 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5713464
Description Jump to:

Cardiac biomarker diagnostic kits market to exhibit dynamic growth during the forecast period

The global cardiac biomarker diagnostic kits market is growing competently, expected to grow at a CAGR of 5.3%. Globally, the rising prevalence of chronic diseases, cardiac disorders along with numerous lifestyle diseases will drive the market growth globally. Major factors such as growing elderly population, increasing hospital admissions for cardiovascular diseases and enhanced product penetration in the developing nations are driving the global market. Present clinical trials for identification of innovative cardiac biomarkers, public and private funding for improved R&D is also increasing the market growth on a global scale. Globally, a gradual shift towards overall treatment along with diagnosis for various lifestyle and chronic diseases is one of the key factors driving the overall growth of the market.

Troponin test kits expected to register higher growth by the end of 2030

The troponin diagnostic test kits estimated to grow significantly during the forecast period, generated maximum revenue in 2021, and estimated to dominate by 2030. Top manufacturers are receiving the U.S. FDA clearance. Product penetration of this segment can be accredited to an increase in the demand for high sensitive troponin assay applications. For e.g. Alere recently launched next generation products such as Troponin I, Cardio2 and Cardio3. Prevalence of acute myocardial infarction (AMI) will boost the need for advanced diagnostic kits on a global scale. Additionally, huge number of pipeline products along with advancement in point-of-care (POC) cardiac testing will increasing the market share of diagnostic kits during the forecast period.

Angina Pectoris segment to witness a significant CAGR

Increasing prevalence of cardiovascular diseases, and growing number of adult population with increased incidence rate of stroke, diseases in the arteries, and other lifestyle diseases will upsurge the market demand for diagnostic kits. As per the statistics by American Heart Association, cardiovascular disease is the leading global cause of death, accounting for more than 17 Mn deaths per year globally, expected to grow to more than 23 million by 2030 worldwide. Additionally, more than 9 million people in the U.S are projected to experience angina pectoris every year, with more than 500,000 new cases of angina pectoris occurring annually. Increasing prevalence of these diseases along with new launch of products for various disease indications globally will further revenue growth during the forecast period. In 2014-2015, stroke and CVD accounted for around 14% of total health expenditures, more than any major diagnostic segment globally. The total direct and indirect costs were more than US$ 350 Bn.

Increased research and development with strong product pipelines in the developed regions

Major manufacturers such as Abbott, Roche, Danaher and others are developing novel products with enhanced applications in the point of care and laboratory testing segment. Increasing demand for laboratory investigation for the identification and diagnostic testing of various cardiac diseases is driving the market growth. Novel diagnostic kit launch with higher compatibility, strategic collaborations, and innovative technology assessment in the emerging countries and improved clinical outcomes in the field of overall cardiac testing globally will further spur revenue growth on a global scale. For e.g. In March 2017, Fujirebio Europe (leader in IVD testing) launched Lumipulse G Myoglobin immunoassays and Lumipulse® G hs Troponin I for both LUMIPULSE G600II and G1200 platforms.

Key Industry Developments:

  • In Oct 2017, Abbott Laboratories completed its acquisition of Alere (leader in rapid point-of-care diagnostics), closing a deal first declared in Feb 2016.
  • In September 2018, Celemics Inc. and Firalis S.A. launched FiMICS® panel. Both declared a definitive agreement for the commercialization of an exclusive proprietary long non-coding RNA (lncRNA) panel.

Top Companies

  • bioMerieux SA
  • Danaher Corporation
  • Guangzhou Wondfo Biotech Co., Ltd
  • Siemens AG
  • Abbott Laboratories
  • Alere, Inc.
  • LSI Medience Corporation
  • Randox laboratories
  • Ortho Clinical Diagnostics
  • Hoffmann-La Roche AG
  • Thermofisher Scientific
  • Bio-Rad Laboratories
  • Others

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Cardiac Biomarker Diagnostic Kits market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Cardiac Biomarker Diagnostic Kits market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product Type

  • Troponin Test Kits
  • CK-MB Test Kits
  • Myoglobin Test Kits
  • BNP Test Kit
  • C-reactive Protein
  • Other Biomarkers

Disease Indication

  • Angina Pectoris
  • Myocardial Infraction (MI)
  • Cardiac Heart Failure

Testing Segment

  • Laboratory Testing
  • Pont-of-care Testing

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Cardiac Biomarker Diagnostic Kits market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Cardiac Biomarker Diagnostic Kits market?
  • Which is the largest regional market for Cardiac Biomarker Diagnostic Kits market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Cardiac Biomarker Diagnostic Kits market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Cardiac Biomarker Diagnostic Kits market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Cardiac Biomarker Diagnostic Kits Market
2.2. Global Cardiac Biomarker Diagnostic Kits Market, By Product Type , 2021 (US$ Million)
2.3. Global Cardiac Biomarker Diagnostic Kits Market, By Disease Indication , 2021 (US$ Million)
2.4. Global Cardiac Biomarker Diagnostic Kits Market, By Testing Segment , 2021 (US$ Million)
2.5. Global Cardiac Biomarker Diagnostic Kits Market, By Geography, 2021 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2021

3. Cardiac Biomarker Diagnostic Kits Market: Competitive Analysis
3.1. Market Positioning of Key Cardiac Biomarker Diagnostic Kits Market Vendors
3.2. Strategies Adopted by Cardiac Biomarker Diagnostic Kits Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030

4. Cardiac Biomarker Diagnostic Kits Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Cardiac Biomarker Diagnostic Kits Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Troponin Test Kits
5.3.2. CK-MB Test Kits
5.3.3. Myoglobin Test Kits
5.3.4. BNP Test Kit
5.3.5. C-reactive Protein
5.3.6. Other Biomarkers

6. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Angina Pectoris
6.3.2. Myocardial Infraction (MI)
6.3.3. Cardiac Heart Failure

7. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2021 Versus 2030
7.3. Market Segmentation
7.3.1. Laboratory Testing
7.3.2. Pont-of-care Testing

8. North America Cardiac Biomarker Diagnostic Kits Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
8.3. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
8.4. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
8.5.Cardiac Biomarker Diagnostic Kits Market: By Region, 2020-2030, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
8.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
8.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
8.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
8.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
8.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
8.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)

9. UK and European Union Cardiac Biomarker Diagnostic Kits Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
9.3. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
9.4. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
9.5.Cardiac Biomarker Diagnostic Kits Market: By Region, 2020-2030, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
9.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
9.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
9.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
9.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
9.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
9.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
9.5.1.4.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
9.5.1.4.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
9.5.1.5. France
9.5.1.5.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
9.5.1.5.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
9.5.1.5.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
9.5.1.6.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
9.5.1.6.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)

10. Asia Pacific Cardiac Biomarker Diagnostic Kits Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
10.3. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
10.4. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
10.5.Cardiac Biomarker Diagnostic Kits Market: By Region, 2020-2030, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
10.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
10.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
10.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
10.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
10.5.1.3. India
10.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
10.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
10.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
10.5.1.4.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
10.5.1.4.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
10.5.1.5.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
10.5.1.5.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
10.5.1.6.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
10.5.1.6.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)

11. Latin America Cardiac Biomarker Diagnostic Kits Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
11.3. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
11.4. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
11.5.Cardiac Biomarker Diagnostic Kits Market: By Region, 2020-2030, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
11.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
11.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
11.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
11.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
11.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
11.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)

12. Middle East and Africa Cardiac Biomarker Diagnostic Kits Market, 2020-2030, USD (Million)
12.1. Market Overview
12.2. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
12.3. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
12.4. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
12.5.Cardiac Biomarker Diagnostic Kits Market: By Region, 2020-2030, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
12.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
12.5.1.1.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
12.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
12.5.1.2.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Product Type , 2020-2030, USD (Million)
12.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Disease Indication , 2020-2030, USD (Million)
12.5.1.3.1. Cardiac Biomarker Diagnostic Kits Market: By Testing Segment , 2020-2030, USD (Million)

13. Company Profile
13.1. bioMerieux SA
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Danaher Corporation
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Guangzhou Wondfo Biotech Co., Ltd
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Siemens AG
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Abbott Laboratories
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Alere, Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. LSI Medience Corporation
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Randox laboratories
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Ortho Clinical Diagnostics
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Hoffmann-La Roche AG
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Thermofisher Scientific
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Bio-Rad Laboratories
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives

List of Figures
Figure 1 Global Cardiac Biomarker Diagnostic Kits Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Cardiac Biomarker Diagnostic Kits Market: Quality Assurance
Figure 5 Global Cardiac Biomarker Diagnostic Kits Market, By Product Type , 2021
Figure 6 Global Cardiac Biomarker Diagnostic Kits Market, By Disease Indication , 2021
Figure 7 Global Cardiac Biomarker Diagnostic Kits Market, By Testing Segment , 2021
Figure 8 Global Cardiac Biomarker Diagnostic Kits Market, By Geography, 2021
Figure 9 Market Geographical Opportunity Matrix - Global Cardiac Biomarker Diagnostic Kits Market, 2021
Figure 10 Market Positioning of Key Cardiac Biomarker Diagnostic Kits Market Players, 2021
Figure 11 Global Cardiac Biomarker Diagnostic Kits Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 12 Global Cardiac Biomarker Diagnostic Kits Market, By Product Type , 2021 Vs 2030, %
Figure 13 Global Cardiac Biomarker Diagnostic Kits Market, By Disease Indication , 2021 Vs 2030, %
Figure 14 Global Cardiac Biomarker Diagnostic Kits Market, By Testing Segment , 2021 Vs 2030, %
Figure 15 U.S. Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 16 Canada Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 17 Rest of North America Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 18 UK Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 19 Germany Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 20 Spain Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 21 Italy Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 22 France Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 23 Rest of Europe Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 24 China Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 25 Japan Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 26 India Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 27 Australia Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 28 South Korea Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 29 Rest of Asia Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 30 Brazil Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 31 Mexico Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 32 Rest of Latin America Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 33 GCC Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 34 Africa Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030
Figure 35 Rest of Middle East and Africa Cardiac Biomarker Diagnostic Kits Market (US$ Million), 2020 - 2030

List of Tables
Table 1 Global Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 2 Global Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 3 Global Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 4 North America Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 5 North America Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 6 North America Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 7 U.S. Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 8 U.S. Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 9 U.S. Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 10 Canada Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 11 Canada Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 12 Canada Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 13 Rest of North America Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 14 Rest of North America Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 15 Rest of North America Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 16 UK and European Union Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 17 UK and European Union Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 18 UK and European Union Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 19 UK Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 20 UK Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 21 UK Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 22 Germany Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 23 Germany Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 24 Germany Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 25 Spain Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 26 Spain Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 27 Spain Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 28 Italy Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 29 Italy Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 30 Italy Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 31 France Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 32 France Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 33 France Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 34 Rest of Europe Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 35 Rest of Europe Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 36 Rest of Europe Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 37 Asia Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 38 Asia Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 39 Asia Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 40 China Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 41 China Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 42 China Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 43 Japan Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 44 Japan Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 45 Japan Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 46 India Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 47 India Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 48 India Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 49 Australia Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 50 Australia Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 51 Australia Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 52 South Korea Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 53 South Korea Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 54 South Korea Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 55 Latin America Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 56 Latin America Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 57 Latin America Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 58 Brazil Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 59 Brazil Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 60 Brazil Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 61 Mexico Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 62 Mexico Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 63 Mexico Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 64 Rest of Latin America Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 65 Rest of Latin America Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 66 Rest of Latin America Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 67 Middle East and Africa Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 68 Middle East and Africa Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 69 Middle East and Africa Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 70 GCC Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 71 GCC Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 72 GCC Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 73 Africa Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 74 Africa Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 75 Africa Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)
Table 76 Rest of Middle East and Africa Cardiac Biomarker Diagnostic Kits Market By Product Type , 2020-2030, USD (Million)
Table 77 Rest of Middle East and Africa Cardiac Biomarker Diagnostic Kits Market By Disease Indication , 2020-2030, USD (Million)
Table 78 Rest of Middle East and Africa Cardiac Biomarker Diagnostic Kits Market By Testing Segment , 2020-2030, USD (Million)

Companies Mentioned

  • bioMerieux SA
  • Danaher Corporation
  • Guangzhou Wondfo Biotech Co. Ltd
  • Siemens AG
  • Abbott Laboratories
  • Alere Inc.
  • LSI Medience Corporation
  • Randox laboratories
  • Ortho Clinical Diagnostics
  • Hoffmann-La Roche AG
  • Thermofisher Scientific
  • Bio-Rad Laboratories .

Related Topics

Related Reports

Cardiac Biomarker Diagnostic Kits Market by Disease, Testing, Product, End-User - Global Forecast 2025-2030 - Product Image

Cardiac Biomarker Diagnostic Kits Market by Disease, Testing, Product, End-User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Cardiac Biomarkers Market Report and Forecast 2024-2032 - Product Image

Cardiac Biomarkers Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Cardiac Marker Testing Market by Product, Biomarker, Type of Testing, Disease - Global Forecast 2025-2030 - Product Image

Cardiac Marker Testing Market by Product, Biomarker, Type of Testing, Disease - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Cardiac Biomarker Diagnostic Test Kits Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Cardiac Biomarker Diagnostic Test Kits Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.